Activist Investors Increase Scrutiny of Public Companies Through SEC Filings Activist investors and investment firms have recently filed formal communications with the U.S. Securities and Exchange Commission (SEC) concerning the …
Tag:
Biopharmaceuticals
-
-
DBV Technologies, a late-stage biopharmaceutical company, will participate in the Guggenheim Securities Emerging Outlook: Biotech Summit. The event will be held on February 11 and 12, 2026 in New York. …